Objective: Cardiac surgery, especially when employing cardiopulmonary bypass and deep hypothermic circulatory arrest, is associated with systemic inflammatory responses that significantly affect morbidity and mortality. Intestinal perfusion abnormalities have been implicated in such responses, but the mechanisms linking local injury and systemic inflammation remain unclear. Intestinal mast cells are specialized immune cells that secrete various preformed effectors in response to cellular stress. We hypothesized that mast cells are activated in a microenvironment shaped by intestinal ischemia/reperfusion, and investigated local and systemic consequences. Design: Rat model of deep hypothermic circulatory arrest. Setting: University research laboratory. Subjects: Twelve-to 14-week-old male Sprague-Dawley rats. Interventions: Rats were anesthetized and cooled to 16°C to 18°C on cardiopulmonary bypass before instituting deep hypothermic circulatory arrest for 45 minutes. Specimens were harvested following rewarming and 2 hours of recovery. Measurements and Main Results: Significant intestinal barrier disruption was found, together with macro-and microscopic evidence of ischemia/reperfusion injury in ileum and colon, but not in the lungs or kidneys. Immunofluorescence and toluidine blue staining revealed increased numbers of mast cells and their activation in the gut. In animals pretreated with the mast cell stabilizer, cromolyn sodium, mast cell degranulation was blocked, and intestinal morphology and barrier function were preserved following deep hypothermic circulatory arrest. Furthermore, cromolyn sodium treatment was associated with reduced intestinal neutrophil influx and blunted systemic release of proinflammatory cytokines. Conclusion: Our data provide primary evidence that intestinal ischemia/reperfusion is a leading pathophysiologic process in a rat model of deep hypothermic circulatory arrest, and that intestinal injury, and local and systemic inflammatory responses are critically dependent on mast cell activation. This identifies intestinal mast cells as central players in deep hypothermic circulatory arrest-associated responses, and opens novel therapeutic possibilities for patients undergoing this procedure. (Crit Care Med 2013; 41:e200-e210) 
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Intestinal Mast Cells Mediate Gut Injury and Systemic Inflammation in a Rat Model of Deep Hypothermic Circulatory Arrest* www.ccmjournal.org e201 C ardiovascular surgery requiring deep hypothermic circulatory arrest (DHCA) is associated with significant hospital morbidity and mortality (1) . In this setting, exposure to the cardiopulmonary bypass (CPB) circuit, alterations in body temperature, and whole-body ischemia/reperfusion (I/R) elicit profound perturbations in inflammatory, hemostatic, and oxidative stress pathways, all implicated in the pathogenesis of an often pronounced systemic inflammatory response syndrome (SIRS).
As many aspects of the pathophysiology of SIRS remain unclear, our efforts to prevent SIRS or its progression to multiple organ failure have remained inadequate. Growing interest has focused on the possibility that the gut is the insidious source of systemic inflammation (2-6). Here, a single-layer epithelial barrier controls compartmentalization of gut-associated immune cells and luminal microbiome. The anoxic lumen of the gut and its dependence on a complex vascular bed provide an anatomical setting in which small changes in blood flow lead to significant disruption of blood supply particularly in the villus tip area (7) . Under such conditions, a microenvironment of closely interrelated hypoxic and inflammatory pathways develops (reviewed by Eltzschig and Carmeliet (8) ) and is associated with barrier dysfunction and epithelial injury in a number of disease models (9, 10) .
Mast cells (MCs) constitute 2% to 3% of lamina propria (11) cells, but are equipped and positioned at the hostenvironment interface to serve as first responders to invading pathogens and cellular stress signals. However, it is now well recognized that MC activation is a prominent feature of intestinal I/R, in which rapid release of preformed MC products is associated with local injury (12) (13) (14) (15) and distal organ effects (16) .
Consequently, we hypothesized that, in a setting of DHCAassociated splanchnic malperfusion, intestinal MC activation contributes to the breakdown of the epithelial barrier and to stimulation of local and systemic inflammatory responses. Our work in a rat model of DHCA provides evidence of MCs as pivotal initiators of early responses to I/R and, as such, potential targets for novel therapeutic interventions in this setting.
MATERIALS AND METHODS
Rat Model of DHCA All procedures were approved by the Duke University Animal Care and Use Committee. Fasting adult male SpragueDawley rats (436.5 ± 34 g, 10-12 wk old) were randomized to four groups based on the institution of DHCA in association with CPB (referred to as DHCA for simplicity) and a drugtreatment regimen. Twelve animals (n = 6 DHCA, n = 6 sham) received 50 mg/kg cromolyn sodium (CS) in physiologic saline by intraperitoneal injections 16 hr before the experiment, after induction of anesthesia, and immediately before reperfusion. Vehicle control animals received physiologic saline correspondingly (n = 6 DHCA and n = 6 sham).
DHCA was instituted as previously described (17) . Briefly, animals were anesthetized with isoflurane (2-2.5 Vol%), intubated and mechanically ventilated (45% O 2 /balance N 2 , PaCO 2 35 to 45 mm Hg). The tail artery and right external jugular vein were cannulated, and 150 IU heparin and 5 μg fentanyl were administered. To allow for later immunolocalization of hypoxic tissues, rats received 60 mg/kg pimonidazole hydrochloride (Hypoxyprobe, HPI, Burlington, MA) through the venous access. Baseline physiologic measurements, including mean arterial pressure (MAP), pericranial and rectal temperature, and blood gas parameters, were recorded beginning 10 minutes before institution of CPB (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/ A614). Animals were then cooled for 30 minutes. Arterial blood gases were maintained using the pH strategy (PaCO 2 31 mm Hg to 40 mm Hg). At a pericranial temperature of 16°C to 18°C, the bypass machine was stopped, and circulatory arrest was maintained for 45 minutes. For rewarming, CPB was reinitiated, and at a pericranial temperature ≥ 35.5°C, animals were separated from CPB. Animals remained ventilated under anesthesia ("recovery") for 2 hr. Euthanasia was performed by cervical dislocation under deep anesthesia. Sham-treated animals were anesthetized, cannulated, and heparinized but did not undergo CPB. Blood pressure was maintained above a MAP of 50 mm Hg by regulating flow rate or administering fluid, but without norepinephrine to avoid associated splanchnic vasoconstriction (18) .
As a reference, a fifth cohort of rats underwent CPB and hypothermia but not circulatory arrest (deep hypothermic cardiopulmonary bypass [DHCPB] ). These animals were pretreated with saline (n = 3).
Histology and Immunohistochemistry
Frozen sections of tissues fixed with Carnoy's fixative were stained with toluidine blue. Hematoxylin and eosin-stained (H&E) sections from formalin-fixed and paraffin-embedded tissue samples were assessed by independent observers blinded to treatment modalities. Renal and pulmonary injury were graded on scales outlined by Jablonski et al (19) and Egan et al (20) . For mesenteric windows, the supporting mesentery of an ileal loop was fixed in Carnoy's and stained with toluidine blue. The percentage of degranulated MCs within the total number of identified MCs was determined in six independent microscopic fields.
For immunohistochemistry, acetone-fixed frozen sections were incubated with one of the following antibodies: rabbit polyclonal carboxypeptidase A3 (1:100; Abbiotec, San Diego, CA), rabbit polyclonal tryptase (1:100; Santa Cruz Biotechnology, CA), or mouse monoclonal anti-Hypoxyprobe (1:50; HPI). TRITC-labeled avidin (1:1000; Sigma Chemical Company, St Louis, MO) was also used for MC staining. Nuclear counterstaining (4′,6-diamidino-2-phenylindole; Vector Laboratories, Burlingame, CA) and epithelial staining with a mouse monoclonal E-cadherin antibody (1:200; BD Biosciences, San Jose, CA) provided further anatomic orientation. FITC and CY3-coupled species-specific secondary antibodies (1:1000; Jackson Laboratories, West Grove, PA) were applied for visualization. Immunohistochemistry for the neutrophil marker Ly-G6 was performed on deparaffinized sections. After antigen retrieval with proteinase K (Sigma), sections were incubated with Ly-6G antibody (1:200, Biorbyt, Cambridge, UK), biotin-coupled secondary antibody (Jackson Laboratories), and AEC peroxidase substrate (Vector Laboratories).
Tissue Assays
Ussing chamber measurements were performed as previously described (21) . In summary, segments of ileum and proximal colon were harvested, and the seromuscular layer was mechanically removed. Tissues were mounted in Ussing chambers with 0.3 cm 2 apertures, and immersed in oxygenated Ringer solution (95% O 2 and 5% CO 2 ) containing 10 mM glucose on the serosal side and 10 mM mannitol on the mucosal side. The spontaneous potential difference (PD) was measured using Ringer-agar bridges connected to calomel electrodes, and the PD was short-circuited through Ag-AgCl electrodes using a voltage clamp. FITC-dextran (2.2 mg/mL, 4.4 kDa; Sigma) was then added to the mucosal reservoir. Samples were harvested from the serosal reservoir at 15-minute intervals for 180 minutes, and the concentration of fluorescein was determined spectrophotofluorometrically (CytoFluo 2300, Millipore, Bedford, MA). Results are reported as the movement of FITC-dextran (mg FITC-dextran/min) for the period of 0-30 minutes and 0-120 minutes. Tissue integrity was verified by maintenance of spontaneous potential difference throughout the measurement, and absence of histological signs of degradation upon completion of the experiment (data not shown).
Myeloperoxidase (MPO) activity was measured in snapfrozen tissue according to the method described by Weiss et al (22) . In brief, tissue was homogenized in potassium phosphate buffer containing 0.5% hexadecyltrimethylammonium bromide (Sigma) and MPO activity was determined by following the oxidation of o-dianisidine in presence of hydrogen peroxide (Sigma).
Malondialdehyde (MDA) and 4-hydroxyalkenals were measured together in tissue homogenates, according to the manufacturer's instructions (OXIS International, Foster City, CA).
For epithelial-enriched fractions, 3 to 4 cm segments of colon were opened and washed. The mucosal side was then mechanically scraped and snap frozen until RNA could be isolated (Macherey-Nagel, Bethlehem, PA). After DNAse digestion and reverse transcription (BioRad, Hercules, CA), quantitative PCR was performed on a CFX96 Real-Time PCR Detection System (BioRad), with β-actin serving as internal standard. Primer and PCR conditions are specified in Supplemental Table 2 (Supplemental Digital Content 1, http://links.lww. com/CCM/A614).
Serum Collection and Assays
Blood samples were collected after induction of anesthesia, 5 minutes after completion of DHCA, and immediately prior to euthanasia. Following centrifugation at 3000 rpm at 4°C, serum was stored at -80°C. Rat cytokines were quantified using a multiplex enzyme-linked immunosorbent assay (ELISA) kit (Millipore, Billerica, MA) and the Bio-Plex detection system (Bio-Rad). Serum histamine concentrations were determined with a competitive histamine ELISA kit (Eagle Biosciences, Nashua, NH). Serum endotoxin levels were measured using an endpoint fluorescent assay (Lonza, Walkersville, MD).
To measure intestinal-type fatty acid-binding protein (FABP-2) levels in serum, black ELISA plates (Thermo Labsystems, Franklin, MA) were coated with an anti-FABP-2 antibody (R&D Systems, Minneapolis, MN). Nonspecific binding was blocked by incubation with blocking buffer (carbonate buffer with 3% nonfat dry milk and 0.1% Kathon). Serum samples were diluted 1:4, and rat recombinant FABP-2 (Cayman Chemical Company, Ann Arbor, MI) served as standard. To detect captured antigen, a biotinylated capture antibody (R&D System), a streptavidin alkaline phosphatase conjugate (Promega, Madison, WI), and the fluorescent alkaline phosphatase substrate AttoPhos (Roche, Indianapolis, IN) were used.
Statistical Analysis
Differences among the four treatment groups were compared separately for each assay using one-way repeated measures analysis of variance (GraphPad Prism, La Jolla, CA). As directed by our hypothesis, we conducted a single post hoc test, evaluating the effect of either DHCA or cromolyn against the respective control using Student t test. Data from perioperative physiological parameters were analyzed using repeated measurements analysis of variance with Bonferroni post hoc testing. Animals treated with DHCPB were excluded from formal statistical analysis due to the limited number (n = 3), but were included in this study for descriptive purposes. Differences were considered significant when a p value of less than 0.05. All error bars represent the SEM.
RESULTS

DHCA is Associated With Ischemia/Reperfusion Injury of the Intestine
In cardiac surgery, systemic responses to DHCA often occur rapidly after reperfusion. To investigate the underlying events, we examined tissue responses in the early phase following DHCA. Two hours after separation from CPB, the primary macroscopic finding was the massive hemorrhagic infiltration of the terminal ileum, which was present in all animals exposed to DHCA (Fig. 1A) . In addition, some vascular injection of the proximal colon was observed, but more proximal gut sections appeared macroscopically normal.
Histology of ileal sections revealed blunting and denuding of intestinal villi and extensive hemorrhage, all typical features of I/R injury (23) . This was associated with a mixed inflammatory infiltrate in the ileum (Fig. 1D , also see Fig. 7A and B) and in colonic sections (Fig. 1E) , where overall injury was less pronounced. In contrast, animals subjected to DHCPB without circulatory arrest, displayed only subtle macroscopic or microscopic abnormalities (data not shown). FABP-2 is a small cytoplasmic protein that readily leaks out of ischemic cells. Significant increase in serum FABP-2 was found www.ccmjournal.org e203 in DHCA animals ( Fig. 2A) and exceeded, by far, the readings in DHCPB-treated animals. Together, these findings establish significant intestinal I/R injury after DHCA, which appeared to be independent of CPB exposure or hypothermia.
Renal and pulmonary dysfunction are common following DHCA. However, histological evidence of early organ injury here was less impressive. In lung sections, some perivascular edema and vascular congestion were observed, but this also occurred in sham-treated (albeit pressure-ventilated) animals. Likewise, in the kidneys, isolated focal and group necroses were observed in some animals after DHCA, but overall changes were subtle (Supplemental Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/A614). This lack of relevant early injury outside the gastrointestinal tract, therefore, suggests that intestinal injury is a primary event following DHCA. We next sought to further define the microenvironmental setting of intestinal injury following DHCA. In contrast to controls ( Fig. 2D and F) , we observed vivid immunolocalization of the hypoxia marker Hypoxyprobe exclusively in the ileal (Fig. 2E ) and colonic mucosa (Fig. 2G) in DHCA rats. Furthermore, epithelial enriched fractions from DHCA-treated animals showed a significant transcriptional induction of a number of oxygen-sensitive genes from both inflammatory and hypoxiaadaptive pathways (Fig. 2B) . Together with the marked increase of the lipid peroxidation product malondialdehyde (MDA) (Fig. 2C) , this characterizes the microenvironment of intestinal injury following DHCA as one of substantial epithelial hypoxia and oxidative stress.
The pivotal manifestation of epithelial ischemia is breakdown of the mucosal barrier. This was assessed in Ussing chambers, which allowed for the ex vivo determination of site-specific intestinal barrier function and confirmed the dramatic disruption of ileal and, to a lesser extent, colonic barrier integrity in DHCA animals (Fig. 3A) . This breach of barrier correlated with a significant increase in serum endotoxin levels at the completion of the experiment indicating substantial bacterial translocation (Fig. 3B) and consequently underlined the relevance of intestinal I/R-type injury in animals subjected to DHCA.
Intestinal I/R Injury is Associated With Local Mast Cell Activation
Because MCs have previously been implicated in intestinal I/R injury, we sought to examine their contribution in our model. As shown in Figure 4A and B, MCs in sham-treated animals were nondegranulated and largely found in the lamina propria. Following DHCA, however, MCs increasingly appeared in the apical regions of the mucosa (Fig. 4C and D) , where the majority was degranulated (Fig. 4C-E) . In the dependent mesenteries, we found a considerable number of MCs in close contact with vascular structures (Fig. 4F) . In DHCA-treated animals, mesenteric MCs were degranulating in 77% ± 14% (Fig. 4G) vs. 15% ± 1% in sham cases (Fig. 4F) , indicating significant MC activation in this compartment. MC numbers and distribution were further examined by analyzing the binding of labeled Avidin to MC granule components (Fig. 5A-D) . This approach confirmed the significant increase of MC numbers, especially in the mucosal compartment, following DHCA (Fig. 5E) .
Intriguingly, a large number of MCs that appeared after DHCA within the intestinal mucosa stained positive for carboxypeptidase A3 (CPA3) (Supplemental Fig. 2B , Supplemental Digital Content 1, http://links.lww.com/CCM/A614), an enzyme generally thought to characterize the connectivetype MC phenotype. Similarly, mRNA profiling of colonic mucosal scrapings revealed a significant increase in signal of the connective-type MC enzymes CPA3 and MC protease-5 and -6 in DHCA rats. In contrast, MC protease-1 and -7 mRNA levels, associated with mucosal MC differentiation, remained stable (Supplemental Fig. 2C , Supplemental Digital Content 1, http:// links.lww.com/CCM/A614). Taken together, these data suggest that splanchnic MC activation after DHCA is associated with changes in MC distribution and phenotype.
Mast Cell Stabilization Protects Against Intestinal I/R Injury and Reduces Inflammatory Responses
We next investigated the implications of MC activation in this model by using systemic MC stabilization with cromolyn sodium (CS). Importantly, in itself, treatment with CS did not significantly affect any of the physiologic parameters charted throughout the experiment (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/ A614). The efficacy of CS was first examined using immunostaining for MC tryptase. Sham-treated animals displayed a punctate staining pattern within the lamina propria, consistent with tryptase contained within intestinal MCs (Fig. 6A) . DHCA animals treated with vehicle demonstrated diffuse release of tryptase into the villus stroma, which coincided with the loss of superficial epithelium in the villus tip region (Fig. 6B) . In contrast, DHCA rats treated with CS retained the circumscript staining pattern seen in sham animals. However, increased numbers of tryptase positive cells again confirmed the increase in MC numbers (Fig. 6C) . In addition, we observed dramatic increases in serum levels of the MC product histamine immediately following reperfusion (Fig. 6D) and during the recovery period in DHCA-treated animals. However, this response was significantly blunted when animals were treated with CS. Animals subjected to DHCPB did not show significant histamine release, suggesting that neither hypothermia nor blood exposure to extracorporeal circulation were major factors in MC activation.
We next examined the effect of CS on the macroscopic ( Fig. 6E compared with Fig. 1A ) and microscopic ( Fig. 6F and G compared with Fig. 1D and E) appearance of the gut in DHCA-treated animals. Almost complete preservation of the intestinal barrier was observed in DHCA animals pretreated with CS. This was underlined in a pathophysiologically relevant manner by significantly lower lipopolysaccharide (LPS) serum levels after DHCA in CS-vs. vehicle-treated animals (Fig. 6H) . Furthermore, measurements of FITC-dextran flux in Ussing chambers showed that the main site of injury, the ileal barrier, was significantly better maintained (DHCA-vehicle vs. DHCA-CS measured from 0 to 120 min: 0.01147 ± 0.00061 mg/min vs. 0.0056 ± 0.00105 mg/min, p ≤ 0.05).
MC activation is critical for neutrophil recruitment. In vehicle-treated animals, a significant number of neutrophils were observed in the intestinal inflammatory infiltrate after DHCA, culminating in crypt abscess-like lesions at the villus base (Fig. 7A and B) . In CS-treated animals, however, abrogation of neutrophil influx was documented histologically (data not shown), by MPO measurements (Fig. 7C) and Ly-6G immunohistochemistry ( Supplemental Fig. 3 , Supple mental Digital Content 1, http://links.lww.com/CCM/A614).
Furthermore, MC stabilization profoundly affected systemic inflammatory responses. A number of proinflammatory cytokines were significantly increased in the serum of DHCA-treated animals 2 hours after separation from CPB (Fig. 8) . However, in DHCA animals pretreated with CS, these responses were blunted for tumor necrosis factor-α, MCP-1, RANTES, interleukin-1β, and the IL-8 homologue GRO/KC, Figure 6 . Cromolyn sodium prevents mast cell activation and maintains intestinal barrier integrity after deep hypothermic circulatory arrest (DHCA). A, Immunohistochemistry of small intestinal sections reveals circumscript staining (white arrows) for mast cell tryptase (red/Cy3: tryptase; blue: 4′,6-diamidino-2-phenylindole nuclear counterstain). B, Following DHCA, tryptase is released into the tissue and is associated with epithelial injury at the villus tip (arrowheads), but in animals pretreated with cromolyn (C), tryptase release is largely prevented (white arrows). D, Serum histamine levels, measured after induction of anesthesia (induction), 5 min after reperfusion (reperfusion), and 2 hr after separation from bypass (recovery). E, Representative photograph of the distal gut portion in a cromolyn-treated rat after DHCA. (Asterisk indicates ileocaecal region; compare with Fig. 1A .) H&E staining of ileum (F) and colon (G) documents preserved wall architecture in cromolyn-treated DHCA animals (compare with Fig. 1D and E) . H, Serum LPS was determined from samples obtained 2 hr after separation from cardiopulmonary bypass. Abbreviations and number of examined animals: Sham/DHCA Vh, pretreatment with saline (vehicle), n = 6 each; Sham/DHCA CS, pretreatment with cromolyn sodium, n = 6 each; DHCPB Vh, deep hypothermic cardiopulmonary bypass, pretreatment with saline, n = 3. Values represent mean ± SEM, *p ≤ 0.05 vs. sham; #p ≤ 0.05 vs. DHCA Vh.
www.ccmjournal.org e207 and showed a trend toward reduction in IL-10. In addition, serum MIP-1α levels were significantly lower in CS-vs. vehicle-treated animals after DHCA. Serum levels of IFNγ (Fig.  8B ), IL-6 (Fig. 8D) , IL-4, and IL-12 (both not shown) did not reveal a clear trend following DHCA with or without CS. These data thus strongly indicate that MC activation plays a pivotal role in the orchestration of local and systemic early inflammatory responses.
DISCUSSION
This study provides evidence that the primary injury in a rat model of DHCA is an intestinal I/R-type injury and highlights the pivotal role of intestinal MCs in associated gut injury and systemic inflammatory responses.
The small intestine constitutes a gut region of special interest in terms of its extensive flora and rich immune cell population. Previous studies collectively emphasize the particular susceptibility of this region to microcirculatory hypoperfusion in the context of cardiac surgery, and have shown an association with intestinal barrier dysfunction, bacterial translocation, and neutrophil infiltration (4, 18, (24) (25) (26) . The histopathological correlate to these reports in our study was a severe I/R-type injury centered around the terminal ileum. As significant injury was absent in other organ systems, this corroborates the notion that intestinal injury is a primary event in DHCA-related inflammatory responses (3, 5, 24, 27) .
Strong evidence suggests that, in the context of intestinal I/R injury, MCs are crucial for translating splanchnic microvascular hypoperfusion into an immune-inflammatory event. However, their role has been poorly integrated into current concepts of the early inflammatory responses following cardiac surgery.
MCs are immune sentinel cells prominently located at the hostenvironment interface, where they limit the spread of invading pathogens (28) , but also serve as first responders to microenvironmental stress. As such, they appear to be exquisitely sensitive to factors of the ischemic microenvironment, e.g., oxidative stress (29) and cell injury (30) . In mesenteric I/R models, 15 minutes of intestinal ischemia was sufficient to elicit significant MC-dependent histamine and MC protease II release (14, 31, 32) . This role as early responders to tissue stress was emphasized by the fact that in addition to early MC degranulation, our model revealed the rapid submucosal accumulation of MCs with a predominant connective tissue phenotype. The distinct staining patterns associated with this phenotypic shift may account for differences to previous studies that had observed decreased MC numbers in intestinal I/R models (13, 14) . However, increased local MC numbers have been associated with inflammation models (33) and brain I/R (34). It remains unclear, whether this is driven by MC recruitment or expansion of tissue-resident precursor cells.
Our work indicates that MCs orchestrate two important pathophysiological aspects of the body's response to DHCA: tissue injury and systemic inflammatory responses. Intestinal I/R models have established the important role of MCs in local inflammation and gut injury using MC-deficient mice (12, 13) and CS (12, 35) . Here, MC tryptase, which is prominently released into the intestinal tissue in our model and, has been implicated in the breakdown of epithelial tight junctions (36, 37) . In addition, although a number of cells are known to secrete TNF-α upon stimulation, MCs (and eosinophils) have the unique ability to store and rapidly release preformed TNF-α (38) . This effectively regulates neutrophil influx and constitutes a major factor in propagating intestinal I/R injury (13, 15, 35 ). Yet, MCs are a relevant source of various cytokines in addition to TNF-α, including, but not limited to, those we saw strongly induced after DHCA (39) . Due to the close proximity of MCs to blood and lymphatic vessels, MC products can rapidly gain access to the circulation and play an important role in the development of SIRS (2, 16, 40) . In accordance, in a neonatal extracorporeal membrane oxygenation (ECMO) model, increases in plasma cytokine concentrations were not mirrored by local transcriptional induction but by decreased tissue cytokine levels (2). Together, this concurs with cytokine release predominantly from preformed stores in this clinical setting. Here, various mechanisms may rapidly amplify the signal of the limited number of mucosal MCs. For example, our data suggest that local signals are enhanced via a "snowball effect" through mesenteric and potentially systemic (41) MC activation. Alternatively, both damage-associated molecular pattern molecules (42) and Paneth cells (43) have been implicated in the development of gut-associated multiple organ dysfunction. This adds further complexity to the mechanisms by which intestinal injury may elicit inflammatory responses. Interestingly, Paneth cell-dependent IL-17 release appears to be TNF-α sensitive (44), suggesting potential cross talk arising from local MC activation.
Overall, this highlights a Janus-headed role of MCs. As pointed out, MCs are essential in limiting pathogen invasion (28), but excessive MC activation is detrimental in various models (16, 41) . In the context of cardiac surgery, the still unclear interplay of several factors may encourage exaggerated MC responses. In addition to microenvironmental conditions, such as hypoxia and oxidative stress (29, 45) , the activation of the complement system during CPB (2) may contribute to MC stimulation (46) . These factors or other signals associated with cardiac surgery may therefore collectively amplify MC responses.
Lastly, although our work suggests that splanchnic MC activation is a key event that shapes early inflammatory responses after DHCA, the impact on clinical outcomes remains undefined. The goal of this work was primarily to characterize the role of preformed MC effectors in DHCA-related pathology, and we concentrated our analysis on the early recovery period to reduce effects from secondary recruitment of further inflammatory cell populations. This limits the conclusions that can be drawn with regard to clinical outcomes, especially because the overall mortality of our protocol is low (17) . However, approximately 50% of animals undergoing www.ccmjournal.org e209 this protocol will later display neurocognitive dysfunction (17) . Therefore, even limited systemic inflammatory responses may be associated with clinically relevant sequelae, e.g. in thoracoabdominal aortic aneurysm repair, with its obligatory visceral I/R, postoperative TNF-α and IL-6 elevations are associated with the increased prevalence of organ dysfunction (47) . Consequently, MC stabilization as a means to reduce early inflammatory signals is an appealing therapeutic target, but further work is needed to address MC-specific outcome modifications.
CONCLUSION
We have characterized intestinal I/R injury as a primary event following DHCA and provide evidence for the previously poorly appreciated role of MCs in the initiation of local and systemic inflammation after DHCA. Furthermore, the successful preclinical trial of a safe and efficient MC stabilizer provides a novel therapeutic opportunity to modify such potentially harmful inflammatory processes.
